Agreement between Framingham-DORICA and SCORE scales in estimation of cardiovascular risk in the patients suffering from metabolic syndrome in Granada (Spain)
- PMID: 21279462
- DOI: 10.1007/s11845-011-0673-9
Agreement between Framingham-DORICA and SCORE scales in estimation of cardiovascular risk in the patients suffering from metabolic syndrome in Granada (Spain)
Abstract
Background and objective: The aim of the present study was to compare the risk stratification obtained with the Framingham function, recommended by the National Cholesterol Education Program (ATP-III), and the risk charts of the Systematic Coronary Risk Evaluation (SCORE) program, in a cohort of subjects between 20 and 75 years (mean 59 years, 70% females) with metabolic syndrome.
Subjects and method: Participants were classified as low, moderate, or high risk by ATP-III and by SCORE of risk at 10 years, respectively.
Results: 8.3% of males and 7.4% of women from our study were classified as high risk in 10 years time by Framingham-DORICA. Regarding SCORE program 50% men and 29.6% of women were considered to have high coronary risk.
Conclusions: Risk estimation with SCORE and Framingham function shows significant gender and quantitative differences. There is no concordance between Framingham and SCORE function to estimate cardiovascular risk on subjects included on the high-risk group.
Similar articles
-
[The application of the SCORE charts to advanced age males triple the number of high-risk subjects compared to the Framingham function].Med Clin (Barc). 2005 Apr 9;124(13):487-90. doi: 10.1157/13073561. Med Clin (Barc). 2005. PMID: 15847765 Spanish.
-
[Cardiovascular risk by Framingham and SCORE in patients 40-65 years old].Med Clin (Barc). 2006 Apr 15;126(14):527-31. doi: 10.1157/13087144. Med Clin (Barc). 2006. PMID: 16756903 Spanish.
-
The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona.HIV Clin Trials. 2016 Jul;17(4):131-9. doi: 10.1080/15284336.2016.1177266. Epub 2016 May 12. HIV Clin Trials. 2016. PMID: 27169692
-
Metabolic syndrome, subclinical coronary atherosclerosis, and cardiovascular risk.Am Heart Hosp J. 2005 Spring;3(2):105-10. doi: 10.1111/j.1541-9215.2005.04441.x. Am Heart Hosp J. 2005. PMID: 15860997 Review.
-
Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk.Int J Clin Pract. 2011 Feb;65(2):134-47. doi: 10.1111/j.1742-1241.2010.02564.x. Epub 2010 Dec 29. Int J Clin Pract. 2011. PMID: 21199197 Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical